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Abstract: Bacillus cereus can cause endophthalmitis through secretion of virulence factors, including hemolysin 
BL (Hbl) and nonhemolytic entertoxin (Nhe). Carvacrol is an extract from oregano oil, with potential for curtailing B. 
cereus endophthalmitis, due to antimicrobial and anti-inflammatory qualities. However, sublethal levels of carvacrol 
increases B. cereus virulence. The goal of this study was to investigate the increase in B. cereus virulence potential 
in response stress induced by a subinhibitory concentration (SIC) of carvacrol. Enterotoxin production and tissue 
damage were examined during ocular infections in vitro and in vivo. We hypothesized that the SIC of carvacrol would 
significantly increase toxin production in B. cereus without progressing systemically. RT-PCR determined SIC carva-
crol-treated B. cereus had significantly higher hblC and nheA mRNA expression levels than controls in vitro. ELISA 
and RPLA analysis revealed a 46.8% and 50% increase in NheA and HblC toxin levels, respectively, in SIC-treated 
cultures. Caenorhabditis elegans-fed SIC carvacrol-treated B. cereus had a significantly higher mean mortality rate 
than nematodes fed untreated B. cereus. Significantly higher TNF-α levels were observed in SIC carvacrol-treated B. 
cereus mice compared to other treatment groups except for mice infected with B. cereus alone. Significantly higher 
IL-6 levels were also found in SIC-B. cereus mice. Histological analysis using Rose-Bengal and DAPI determined that 
the eyes of mice infected with SIC carvacrol-treated B. cereus had significantly more damage than eyes treated with 
B. cereus alone. The SIC of carvacrol increased B. cereus virulence in vitro and in vivo, with a mild systemic infec-
tion noted. 
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Introduction
Bacillus cereus is a Gram-positive, rod-shaped, 
spore-forming bacterium that, in addition to 
being well-known in foodborne illness [1], is 
capable of causing endophthalmitis [2, 3]. B. 
cereus produces a variety of damaging toxins 
that play an important role in virulence during 
infection with endophthalmitis. Most of these 
toxins are under control of the global transcrip-
tional regulator PlcR, including hemolysin BL 
(Hbl), nonhemolytic enterotoxin (Nhe), and cyto-
toxin K (CytK) [4]. B. cereus is the second most 
common source of posttraumatic endophthal-
mitis, next to Staphylococcus aureus [3]. Of the 
exotoxins and enzymes known to be produced 
by B. cereus, only Hbl has been studied in the 
context of endophthalmitis [5, 6], where it has 
been shown to cause irreversible tissue dam-
age to retinal photoreceptors in less than 24 
hours, resulting in blindness [7, 8]. However, 
additional virulence determinants are possibly 
involved in B. cereus endophthalmitis, some 
of which may facilitate localized inflammation 
and/or dissemination of bacteria into the 
peripheral blood.
Endophthalmitis is an inflammatory infection 
that occurs after introduction of bacteria into 
the posterior segment of the eye [3]. Because 
of its motile nature, B. cereus has been known 
to rapidly migrate from the vitreous of the eye 
to other intraocular structures as early as nine 
hours after initial infection. Although damage to 
the blood-retinal barrier is often a consequence 
of B. cereus endophthalmitis, a systemic infec-
tion is not typically observed. 
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The observed eye infection is difficult for health 
professionals to immediately diagnose precise-
ly. Thus, a broad-spectrum of antibiotics is 
commonly administered [3]. However, the eye is 
an immunoprivileged site and oral or intrave-
nous antibiotics are typically not effective. The 
most common treatment is the injection of van-
comycin and an aminoglycoside or cephalospo-
rin directly into the vitreous of the eye. Because 
amikacin (an aminoglycoside) is toxic to sensi-
tive retinal cells, ceftazidime (a cephalosporin) 
is often preferred. Unfortunately, B. cereus is 
not always responsive to this drug and in worse 
case scenarios a vitrectomy may be done as a 
fast and effective way to drain the eye of fluid 
containing the causative bacteria, toxins, and 
host inflammatory cells [9].
While intravitreal antibiotics are capable of 
effectively controlling B. cereus endophthalmi-
tis, potential problems caused by the host 
inflammatory response remain. In response to 
ocular infection with B. cereus, a variety of pro-
inflammatory cytokines are produced by Müller 
cells, astrocytes, and pericytes [1, 6]. TNF-α 
and IL-6 are two pro-inflammatory cytokines 
produced in the eye during endophthalmitis [3]. 
TNF-α signals polymorphonuclear leukocytes to 
rapidly migrate to the site of infection within the 
eye, causing extensive inflammatory damage 
along the way [6]. IL-6 is stimulated by TNF- α, 
and plays a role in the differentiation of B- and 
T-lymphocytes [6]. Antibiotic treatment fre-
quently causes structural damage to bacteria, 
and release of various components, especially 
peptidoglycan antigens, augmenting the host 
inflammatory response. For this reason, many 
doctors choose to supplement their antibiotic 
regime with a corticosteroid such as dexameth-
asone in an attempt to suppress additional 
ocular damage caused by inflammation. 
However, studies have shown that the addition 
of dexamethasone is futile, if not detriment- 
al, to intraocular antibiotic treatment [10]. 
Because host inflammatory cells cause so 
much collateral damage during infection with 
endophthalmitis, there is a great need for a 
drug capable of inhibiting the inflammatory 
response within the eye.
Many phenolic compounds found in plants 
have antimicrobial, antioxidant, and anti-inflam-
matory capabilities [11]. Carvacrol is a compo-
nent of oregano oil that displays all of these 
qualities. Carvacrol works by disrupting the 
cell membrane of B. cereus and causing it to 
swell while releasing intracellular ATP [12, 13]. 
Carvacrol also disrupts the K+ ion gradient with-
in the cell membrane and is lethal to B. cereus 
at concentrations exceeding 1 mM [14]. How- 
ever, it is the anti-inflammatory qualities of car-
vacrol that render it most useful as a possible 
treatment for endophthalmitis. In particular, 
carvacrol is known to inhibit TNF-α and IL-6 
expression at both transcriptional and transla-
tional levels, along with other pro-inflammatory 
cytokines in vitro [15]. Carvacrol may be an 
alternative treatment to antibiotics because of 
its ability to kill bacterial cells while also sup-
pressing the host inflammatory response.
Although carvacrol can effectively control B. 
cereus growth, it is very important to adminis-
ter this chemical compound at the correct con-
centration. B. cereus has been documented to 
adjust to carvacrol at concentrations of 0.4 mM 
or below [16]; changing its fatty acid content 
after exposure to these subinhibitory concen-
trations (SIC). This mechanism most likely is an 
attempt to protect its intracellular ATP and K+ 
ions. Studies performed in this laboratory have 
determined that the SIC of carvacrol against B. 
cereus ATCC14579 is 1 mM, and early experi-
ments indicated that in vitro toxin production 
increased compared to that in non-stressed 
cultures. 
In this study, we hypothesized that the addition 
of carvacrol at the SIC would increase the viru-
lence of B. cereus and result in more extensive 
eye tissue damage than B. cereus alone. We 
also hypothesized that the endophthalmitis 
infection would not progress into a systemic 
infection. This study is important because it 
investigates the behavior of B. cereus in re- 
sponse to a potential alternative treatment for 
endophthalmitis. This study is also unique 
because the antimicrobial and anti-inflammato-
ry qualities of carvacrol have yet to be tested in 
an ocular infection model. 
Materials and methods
Determination of carvacrol subinhibitory con-
centration (SIC)
Bacillus cereus ATCC 14579 was cultured in 
Mueller-Hinton broth (Sigma-Aldrich, St. Louis, 
MO) at 32°C while shaking at 200 rpm. This 
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strain has previously been shown to harbor and 
express the Hbl and Nhe enterotoxin operons 
[17]. Mueller-Hinton broth tubes (fifteen) were 
seeded with B. cereus at a concentration of 102 
CFU/ml (colony-forming units ml-1, mid-log 
phase 32°C saline-washed cells). Carvacrol 
(SAFC Supply Solutions, St. Louis, MO) was 
added to each tube in a 1:2 dilution series 
beginning at 256 mM. All tubes were assessed 
by O.D. (600 nm) measurements taken after 
dilutions had been performed as well as by 
standard plate count (SPC) onto Mueller-Hinton 
agar (Sigma). Tubes were incubated at 32°C for 
24 h (shaking at 200 rpm) after which time 
growth was assessed by again measuring O.D. 
(600 nm) and SPC. The highest carvacrol con-
centration allowing for bacterial growth was 
determined to be the SIC (whereas the lowest 
carvacrol concentration preventing measure-
able growth was the minimum inhibitory con-
centration; MIC). This and all experiments were 
performed in quadruplicate unless otherwise 
indicated. 
nheA and hblC expression in vitro
Total RNA isolation from untreated and SIC car-
vacrol-grown B. cereus was performed as in 
Gracias and McKillip [18] using Trizol reagent 
(Life Technologies, Grand Island, NY) and 1.5 
mL of culture incubated as previously described. 
Final RNA pellets were resuspended in sterile 
nuclease-free water DNase-treated, quantified 
spectrophotometrically, and purity determined 
using A260/A280 ratio values prior to reverse 
transcriptase polymerase chain reaction (RT- 
PCR) setup. 
All RNA samples from SIC carvacrol-treated cul-
tures were standardized to a concentration of 
0.5 μg/μl for RT-PCR using a MasterAmp™ High 
annealing, and 72°C extension phase. A confir-
matory melting curve analysis was included at 
the end of each run. All PCR was performed on 
a Cepheid SmartCycler (Cepheid, Sunnyvale, 
CA). All RT-PCR reactions were completed in 
quadruplicate and CT value means were ana-
lyzed using a Student’s t-test (P<0.05).
Standard curves were completed for relative 
quantification of nheA and hblC expression. 
Mid-log phase B. cereus total RNA was extract-
ed and serially diluted 1:2 in sterile nuclease-
free water, starting at 10 μg/μl of RNA to 0.31 
μg/μl, with 1 μl of RNA being used for each of 
triplicate reactions at each dilution using the 
conditions described below. Resulting mean 
cycle threshold (CT) values were plotted against 
RNA concentrations to provide a standard 
curve against which relative expression levels 
were compared versus a housekeeping gene 
control, gyrB. 
HblC and NheA toxin Immunoassays 
B. cereus control samples were inoculated in 
Mueller Hinton broth 6 h prior to assay. For 
stress treatments, B. cereus stress samples 
were inoculated with carvacrol at the desired 
concentration as described previously (1 mM, 2 
mM, 8 mM) 6 h prior to the assay. B. cereus 
control samples (1 ml) from each tube sample 
per replicate lane was centrifuged at 1,000xg 
for 20 min at 4°C. 
In order to ascertain presence of the B. cereus 
L2 component of Hbl toxin in treatments, the 
BCET-RPLA kit (Oxoid Limited #TD0950, Ba- 
singstoke Hampshire, UK) was performed 
according to manufacturer’s instructions, using 
serially diluted culture supernatant for relative 
quantification of toxin. Additionally, the NheA 
Table 1. Forward and reverse RT-PCR primers used in this study
Designation 5’→3’ Primer Sequence GenBank Accession or reference
hblC forward AATGGTCATCGGAACTCTAT 17
hblC reverse CTCGCTGTTCTGCTGTTAAT 76
nheA forward TACGCTAAGGAGGGGCA 76
nheA reverse GTTTTTATTGCTTCATCGGCT 76
plcR forward ACTAGGATCCATGCAAGCAGAGAAATTAG 91897266
plcR reverse ACTAAGGTCCTTATCTGCTGATTTTATTTAC 91897267
gyrB forward GCGTTAGAAGTTTCAAGTTTAC AF090330
gyrB reverse CCGATTGCCGTAATAATTGTAC AF090330
Fidelity RT-PCR Kit (Epicen- 
tre Biotechnologies, Madison, 
WI) and included 12.5 µl 
MasterAmp 2X RT-PCR pre-
mix, 0.5 µl MMLV RT Plus 
enzyme, 0.5 µl MasterAmp 
TAQurate DNA Polymerase 
Mix, 100 pmol each primer 
(Table 1), RNA template, and 
sterile nuclease-free water to 
a total volume of 25 µl. 
Cycling parameters were 42 
cycles of a 94°C 1 min. dena-
turation, 53°C 1 min. primer 
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component of the B. cereus Nhe toxin complex 
was quantified by enzyme-linked immunosor-
bent assay (ELISA) using the TECRA-BDE kit 
(Tecra #BDEVIA48, Frenchs Forest, Australia) 
according to instructions provided. All immuno-
assays were performed in quadruplicate and 
results used for statistical analyses using a 
one-way t-test (P<0.05).
C. elegans in vivo bioassay model
Overnight B. cereus ATCC14579 control sam-
ples were inoculated in Tryptic Soy Broth (TSB, 
Weber Scientific, Hamilton, NJ) 6 h prior to the 
assay and incubated at 32°C while shaking 
at 200 rpm. For stress treatments, B. cereus 
stress samples were inoculated into TSB with 
SIC carvacrol as described previously. Caeno- 
rhabditis elegans (Carolina Biological, Durham, 
NC USA) were propagated on Nematode Growth 
Agar (NGA) plates (Carolina) containing a lawn 
of E. coli strain OP50 for approximately 48 h 
prior to separation into different treatment 
groups. B. cereus untreated, B. cereus with SIC 
carvacrol, B. cereus with MIC carvacrol, and E. 
coli alone were plated onto separate NGA 
plates (Carolina) after reaching an OD600 of 
0.25. Starting at 48 h after the separation into 
treatment groups, C. elegans were monitored 
for mortality every 24 h for 120 h total. Data 
were collected at 48 h, 72 h, 96 h, and 120 h 
by averaging ten replicates per treatment/time-
point and statistically analysed using one-way 
ANOVA (P<0.05). Mean internal volume calcula-
tions were also performed for each nematode 
treatment group (using mean πr2 h values) but 
were not used for data analysis comparisons.
Mouse in vivo bioassay model-bacteria prepa-
ration 
Bacillus cereus ATTC14579 was cultured in 
Tryptic Soy Broth (TSB) (Weber Scientific) and 
incubated at 30°C under aeration at 150 rpm. 
B. cereus was also cultured in the same way 
with the 1 mM SIC of carvacrol. The bacteria 
were sub-cultured twice before being adminis-
tered to mice at 5 × 107 CFU in sterile saline.
In vivo infection with Bacillus cereus + SIC of 
carvacrol 
All experiments were performed following ap- 
proval from the Ball State University Institutio- 
nal Biosafety Committee (IBC), as well as the 
Institutional Animal Care and Use Committee 
(IACUC). CITI certification was also obtained. 
Fifteen BALB/c mice approximately 10 weeks 
of age were acquired from Jackson Laboratory 
(Bar Harbor, ME) and placed in separate cages 
according to gender. Three BALB/c mice were 
randomly assigned to each of five different 
treatment groups. Mice were anesthetized with 
an intraperitoneal injection of ketamine (50 
mg/kg body weight) and xylazine (5 mg/kg 
body weight) (Henry Schein, Melville, NY) prior 
to infection in order to facilitate bacterial ino- 
culation by eye drops in each eye. The five treat-
ment groups consisted of 1) a negative control 
group receiving only saline, 2) an experimental 
control group receiving only the SIC of carvacrol 
without bacteria, 3) a positive control group 
receiving 5 × 107 CFU of B. cereus in saline, 4) 
an experimental group receiving 5 × 107 CFU of 
B. cereus cultured with the SIC of carvacrol, 
and 5) a second positive control group receiv-
ing an intraperitoneal injection of 5 × 107 CFU 
of B. cereus alone (the latter serving as a cyto-
kine-induced positive control group). Mice were 
infected with the same volume (15 μl) in each 
eye by micropipet. The mice were closely moni-
tored throughout the infection period of 14 
days, after which they were sacrificed.
In vivo infection-tissue preparation 
After a 14 day immune challenge, spleens were 
immediately harvested from each mouse and 
stored in ice-cold lysis buffer (150 mM NaCl; 50 
mM Tris pH 7.4; 1 mM EDTA) (Amresco, Solon, 
OH). The spleen tissue was homogenized and 
centrifuged at 2K × G for three minutes at 
4°C, after which the supernatant was collected 
and stored at -20°C for future use in ELISA 
experiments. The eyes were also harvested 
immediately and stored in an eye tissue fixa- 
tive solution (4% paraformaldehyde (Thermo 
Scientific, Rockford, IL) containing 20 μl 10 N 
NaOH added dropwise (Sigma-Aldrich). After 
removing the lens, the eyes were stored at 
-20°C for future histological analysis. 
In vivo infection-ELISA-based TNF-α, IL-6, and 
IgG measurement
Spleen lysates for each mouse were used to 
detect the presence of pro-inflammatory cyto-
kines TNF-α and IL-6, as well as to ascertain 
IgG induction against B. cereus in a systemic 
immune response. Direct ELISAs were per-
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formed using the Mouse TNF-α ELISA Ready-
SET-Go!® (eBioscience, San Diego, CA) and 
Mouse IL-6 ELISA Ready-SET-Go!® (eBiosci-
ence) kits following the manufacturer’s instruc-
tions. A TNF-α protein standard (eBioscience) 
and IL-6 protein standard (eBioscience) were 
diluted according to the manufacturer’s ins- 
tructions and used for the construction of stan-
dard curves in order to determine protein con-
centrations. An indirect ELISA was also per-
formed by coating the 96-well plate (Falcon 
3911 MicroTest III Flexible Assay Plate, Becton 
Dickinson Labware, Oxnard, CA) with a combi-
nation of 86% phenol (Sigma-Aldrich), 0.25% 
glutaraldehyde (Eastman Kodak Company, 
Rochester, NY) and 5 × 107 CFU B. cereus sus-
pended in sterile saline. After coating the plate, 
the ELISA was performed following the manu-
facturer’s instructions. Absorbance values we- 
re measured by the Bio-Rad Model 680 Mic- 
roplate Reader at 450 nm. All readings were 
taken in triplicate for statistical analyses.
In vivo infection - histological analysis of eye 
tissue 
Fixed mouse eyes were sectioned at 12 μm 
thickness using a MICROM HM 505 N cryostat. 
Each eye was stored in 30% sucrose (Life 
Technologies, Carlsbad, CA) cryoprotectant at 
least 24 hours prior to sectioning and trans-
ferred into OTC prior to slicing. For each eye, 
five slides were prepared using TRUBOND 380 
Microscope Slides (Tru Scientific, Bellingham, 
WA). Each slide contained three slices of eye 
tissue.
Eye tissue slides were then stained with 1% 
DAPI (Life Technologies) for four minutes and 
0.001% Rose Bengal (Sigma-Aldrich) for 12 
minutes while gently rocking. Undamaged eye 
tissue is stained blue by DAPI, while Rose 
Bengal stains damaged tissue red. After wash-
ing with 1 × PBS (Fisher Scientific), the slides 
were imaged using a Cannon powershot A650IS 
digital camera attached to a Zeiss 25 ICS TLM 
(with fluorescence filters). The images acquired 
at 100 × magnification were analyzed using 
Image-Pro Express 6.0 software. Data for each 
slide were averaged, resulting in a single mean 
intensity value for red spectrum fluorescence 
and blue spectrum fluorescence in each eye.
In vivo infection-statistical analysis 
A one-way ANOVA using the Tukey’s Pairwise 
Comparisons Test was performed on the log-
transformed mean protein concentrations ob- 
tained from TNF-α and IL-6 direct ELISAs in 
order to meet the required assumptions for 
this statistical test. A one-way ANOVA using the 
Tukey’s Pairwise Comparisons Test was also 
performed on the mean O.D. values of the indi-
rect ELISA without a need for data transforma-
tion. Mean red intensity values for fluorescently 
stained ocular tissue were transformed to the 
fourth power in order to meet the assumptions 
required for statistical analysis using a one- 




After performing a carvacrol dilution series, 
testing indicated that 1 mM carvacrol was the 
SIC and 2 mM carvacrol was the minimum 
inhibitory concentration (MIC) based on OD 
measurements and recovered viable cell cou- 
nts from broth dilutions. This finding is consis-
tent with the literature. We therefore confirmed 
the carvacrol dose necessary to sublethally 
injure B. cereus so that we could assess if there 
is an increase or decrease in hblC and nheA 
gene expression.
RNA standard curves
RNA primer standard curves were generated 
using total RNA extracted from TSB-grown B. 
cereus ATCC14579 and primers specific for tar-
get gene mRNA gyrB (positive control), hblC, 
and nheA. RNA standard curves were perfor- 
med in order to standardize the RNA concentra-
tions among control vs carvacrol-treated cells 
in this study, allowing for relative quantification 
of expression compared to a housekeeping 
control. When assessing cycle threshold (CT) 
values, results indicate that SIC levels of carva-
crol down-regulate mRNA expression of hblC on 
average 12.9% compared to the control cul-
tures in B. cereus (Table 2), a statistically sig-
nificant difference. The housekeeping gene 
gyrB was also significantly downregulated by 
30.7% (Table 2) in response to SIC carvacrol, 
while the enterotoxin gene nheA was upregu-
lated 4.9% (but was not considered statistically 
significant compared to untreated B. cereus). 
Toxin protein production
Commercial immunoassay toxin kits were per-
formed to determine if the carvacrol-mediated 
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Table 2. 1 mM carvacrol (SIC) exposure causes mRNA down-regu-
lation in gyrB, hblC, and up-regulation of nheA
Gene 
target
B. cereus control 
mean CT value
Carvacrol-treated B. 
cereus mean CT value
Carvacrol treated 
B. cereus mean CT 
value
gyrB 15.46 ± 0.94 (n = 14) 20.21 ± 1.9 (n = 14) 30.7% decrease*
hblC 14.96 ± 0.46 (n = 36) 16.89 ± 0.81 (n = 36) 12.9% decrease**
nheA 14.56 ± 0.62 (n = 17) 13.85 ± 0.50 (n = 17) 4.9% increase
B. cereus gyrase subunit B gene was used as a housekeeping control. Relative gene 
expression changes were measured by mean cycle threshold (CT) values. All RT-PCR 
reactions were completed in quadruplicate and CT value means were analyzed us-
ing a Student’s t-test. All data were expressed as + S.E.M. and the criterion used to 
assess significance was set at P<0.05. n = number of samples tested. *Statistically 
significant versus nonstressed control (P = 0.035). **Statistically significant versus 
nonstressed control (P = 0.04).
decrease in mRNA expression of hblC would 
correspond to a decrease in HblC protein ex- 
pression as well. ELISA analysis revealed a 
46.8% increase in NheA protein toxin in res- 
ponse to 1 mM carvacrol (SIC) exposure when 
compared to non-stressed bacteria. RPLA anal-
ysis showed a 50% increase in HblC protein 
toxin expression in response to SIC levels of 
carvacrol (data not included). However, a 2 mM 
(MIC) or higher (8 mM concentration) of carva-
crol inhibits any detectable level of either HblC 
or NheA proteins.
Carvacrol effects on B. cereus virulence in 
Caenorhabditis elegans
C. elegans mortality was selected as the mea-
sure of choice for quantifying the effect of car-
vacrol-treated B. cereus in vivo. The SIC car- 
vacrol/B. cereus-fed group showed a statisti-
alone (Figure 2A). Mice injected intraperitone-
ally with B. cereus displayed lower TNF-α le- 
vels, but not significantly different levels from 
mice treated with B. cereus alone. Mice treated 
with SIC carvacrol alone had significantly lower 
detectable TNF-α levels than any other group.
IL-6 pro-inflammatory cytokine expression dur-
ing B. cereus ocular infection
Mice infected with SIC carvacrol-treated B. 
cereus had significantly higher detectable IL-6 
levels in the spleen than those of all other treat-
ment groups except for mice injected intraperi-
toneally with B. cereus (Figure 2B). No signifi-
cant difference was observed in detectable IL-6 
levels among the saline control mice, the mice 
infected with B. cereus alone, and the mice 
injected with B. cereus. Mice infected with SIC 
carvacrol alone had significantly lower detect-
able IL-6 levels than all other treatment groups.
Anti-B. cereus IgG levels during ocular infec-
tion 
Mice infected with SIC carvacrol-treated B. 
cereus had significantly higher detectable IgG 
levels than mice infected with B. cereus alone 
(Figure 2C). No significant difference was ob- 
served between mice infected with SIC carva-
crol-treated B. cereus via the eye and mice 
injected intraperitoneally with B. cereus how- 
ever. 
Histological analysis of tissue damage during 
B. cereus ocular infection 
Verification of B. cereus infection was noted as 
a decrease in eye tissue integrity and by the 
Figure 1. Mean mortality percentages were calcu-
lated for C. elegans fed with different treatments of 
bacteria at 48 h, 72 h, 96 h, and 120 h. Statistical 
analysis was performed on data obtained after 48 
h. Asterisks denote a significant difference between 
B. cereus stressed with the SIC of carvacrol and all 
other treatment groups at that time point (P<0.05).
cally significant increase in mor- 
tality after 96 h and 120 h com-
pared to nematodes reared on 
only E. coli or only untreated B. 
cereus (Figure 1). 
TNF-α pro-inflammatory 
cytokine expression during B. 
cereus ocular infection 
Mice infected with SIC carva-
crol-treated B. cereus had sig-
nificantly higher detectable TNF- 
α levels in the spleen than all 
other treatment groups except 
for mice treated with B. cereus 
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Pairwise Comparisons Test (Mean log protein con-
centration ± SEM). Treatment groups with different 
letters are significantly different (P<0.05). B. Rela-
tive difference of mean IL-6 levels in mice following 
ocular infection with Bacillus cereus ATCC14579 as 
indicated by treatment group on the x-axis: 1 = IP in-
jected B. cereus; 2 = B. cereus alone; 3 = B. cereus 
+ SIC of carvacrol. Mean log IL-6 protein concentra-
tions were obtained from ELISA analysis of spleen 
lysates for three mice within each treatment group 
and compared using a one-way ANOVA with Tukey’s 
Pairwise Comparisons Test (Mean log protein con-
centration ± SEM). Treatment groups with different 
letters are significantly different (P<0.05). C. Mean 
A450 values were obtained using indirect ELISA of 
spleen lysates for three mice within each treatment 
group to assess relative levels of anti-B. cereus IgG. 
X-axis labels 1 = IP injected B. cereus; 2 = B. cereus 
alone; 3 = B. cereus + SIC of carvacrol. Mean A450 
values were compared using one-way ANOVA with a 
Tukey’s Pairwise Comparisons Test (Mean A450 value 
± SEM). Treatment groups with different letters are 
significantly different (P<0.05).
presence of the bacteria in Gram-stained sec-
tions. Overall, mouse eyes treated with SIC of 
carvacrol alone had better tissue integrity, with 
more eye layers present than any other group 
(Figure 3, picture 1 insert). Mouse eyes infect-
ed with SIC carvacrol-treated B. cereus dis-
played a lower level of tissue integrity upon 
examination. Fluorescently staining the tissue 
with DAPI and Rose Bengal red resulted in sig-
nificantly higher red saturation intensity values, 
and therefore, verified that the tissue displayed 
more damage when the eyes were infected with 
B. cereus alone than eyes treated with saline 
(Figure 3). However, eyes infected with SIC car-
vacrol-treated B. cereus and eyes treated with 
SIC carvacrol alone were not significantly differ-
ent from each other. This may be due to the 
actual presence of more layers in the SIC carva-
crol alone group which often fluoresced red.
Discussion
This study examined the effect of an essential 
oil (carvacrol) as a possible treatment option 
other than antibiotics for B. cereus induced 
endophthalmitis and the possible consequenc-
es of SIC use. Because retinal photoreceptor 
cells are sensitive to exogenous antigens, the 
inflammatory response, and high doses of anti-
microbial agents [19-22], exploration of novel 
infection control strategies is vital. Since carva-
crol has been previously shown to kill vegeta-
tive B. cereus [12, 14], along with exhibiting 
Figure 2. A. Relative difference of mean TNF-α 
levels in mice following ocular infection with Bacil-
lus cereus ATCC14579 as indicated by treatment 
group on the x-axis: 1. SIC of carvacrol alone; 2. IP 
injected B. cereus; 3. B. cereus alone; 4. B. cereus 
+ SIC carvacrol. Mean log TNF-α protein concentra-
tions were obtained from ELISA analysis of spleen 
lysates for three mice within each treatment group 
and compared using a one-way ANOVA with Tukey’s 
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in many bacterial pathogens but never conclu-
sively measured [24, 25]. 
SIC-mediated effects on virulence gene mRNA 
levels in B. cereus were augmented by immuno-
assay of protein toxin production in broth under 
the same level of stress. ELISA analysis 
revealed a 46.8% increase in NheA protein 
toxin in response to 1 mM carvacrol (SIC) expo-
sure compared to untreated controls while 
RPLA analysis revealed a mean 50% increase 
in HblC protein toxin expression in response to 
SIC levels of carvacrol. However, a 2 mM (MIC) 
or 8 mM concentration of carvacrol inhibited 
any detectable level of either the HblC or NheA 
proteins, as would be expected. This finding 
could be attributed to translation of existing 
mRNA toxin transcripts synthesized prior to 
and during carvacrol exposure. The possibility 
exists that SIC carvacrol stress decreases 
mRNA turnover in treated B. cereus compared 
to control cultures, an avenue we are current- 
ly exploring. It has been shown in a previous 
study that B. cereus enterotoxin gene transcrip-
tion and Nhe/Hbl protein titers vary greatly in a 
strain-specific manner, even to the extent of 
great incongruence between mRNA levels and 
corresponding toxin levels within the same 
strain [26]. The complex regulatory network at 
play in this group of bacteria is only partially 
elucidated, involving the redox-sensitive ResDE 
network, PlcR, CodY, and likely many other yet-
to-be identified transcriptional effectors, delay-
ing our full understanding of quorum sensing 
and stress response mechanisms in Bacillus 
spp. [27, 28]. In light of the state of the field cur-
rently, our results demonstrate that a sublethal 
dose of carvacrol increases HblC and NheA 
enterotoxin production substantially over non-
stressed bacteria while only modestly increas-
ing (or opting to not downregulate) transcription 
of hblC and nheA. This is clinically relevant, as 
a sublethal dose (1 mM) of carvacrol adminis-
tered clinically could easily exacerbate endo-
phthalmitis tissue damage and perhaps result 
in a systemic infection. 
In vivo work substantiated these findings. Since 
the SIC carvacrol-treated C. elegans group 
showed a statistically significant increase over 
any other treatment group in mortality rate 
after 96 h and 120 h, the hypothesis that SIC 
carvacrol increases the virulence of B. cereus 
is supported. The specific nature of these viru-
anti-inflammatory properties (COX-2 inhibitor) 
[12, 14], it may show further promise as a treat-
ment option for endophthalmitis.
Our results show that SIC levels of carvacrol 
downregulate mRNA expression of hblC on 
average 12.9% compared to the control cul-
tures in B. cereus. Interestingly, our housekeep-
ing control gene (gyrB) was downregulated 
30.7% in response to SIC carvacrol treatment 
as well, at the same cell density and total RNA 
yield as in other treatments, suggesting a 
global stress-induced down-regulation of gene 
expression when grown under this chemical 
stressor. Thus, hblC was downregulated to a 
significantly less degree compared to the hou- 
sekeeping gene, underscoring the differential 
regulation of the Hbl operon. Moreover, even 
under these SIC carvacrol stress circumstanc-
es, nheA was upregulated by 4.9%, indicating 
some degree of expression of virulence genes 
are needed by the pathogen when presented 
with a sublethal chemical injury such as carva-
crol, a phenomenon that has been suspected 
Figure 3. Relative difference of mean fluorescent red 
intensity values in mouse eyes (n = 6), representing 
ocular tissue damage after infection with B. cereus. 
X-axis labels 1. SIC carvacrol alone; 2. B. cereus 
alone; 3. B. cereus + SIC of carvacrol. Mean intensity 
values were obtained from mouse eye cryosections 
stained with DAPI and Rose Bengal using Image Pro 
Express 6.0 software. Picture inserts demonstrate 
the integrity of the tissue samples. 1. SIC carvacrol 
alone presents the best tissue integrity, Mean in-
tensity values were transformed to the fourth power 
and compared using a one-way ANOVA with Tukey’s 
Pairwise Comparisons Test (Mean intensity value ± 
SEM). Treatment groups with different letters are sig-
nificantly different (P<0.05).
Carvacrol effects on Bacillus cereus virulence
19 Int J Biochem Mol Biol 2018;9(2):11-21
lence factors was not elucidated in this study, 
which are likely a coordinately regulated set of 
products from multiple operons. If the C. ele-
gans mortality rates for each treatment group 
are any indication of their health in the MIC 
and SIC concentrations of carvacrol, this exper-
iment supports the hypothesis that SIC carva-
crol increases the virulence of B. cereus, and 
thus increases the mortality rate of C. elegans. 
This finding is significant because it emphasiz-
es the importance of treating B. cereus ocular 
infections with the appropriate concentration 
of carvacrol. 
Our in vivo results from the mouse model, spe-
cifically on the ELISA-based detection of TNF-a 
and IL-6 from spleen lysates, support the notion 
that at least a modest systemic bacterial infec-
tion (and enhanced virulence) does occur from 
ocular introduction of SIC carvacrol-treated B. 
cereus. To the authors’ knowledge, this is the 
first published report of a B. cereus-mediated 
ocular infection progressing systemically. The 
goal of this aspect of the study was to deter-
mine whether or not the SIC of carvacrol 
increases virulence of B. cereus during infec-
tion with endophthalmitis in mice. 
We have determined that mice infected ocular-
ly with B. cereus and the SIC of carvacrol have 
an increased systemic pro-inflammatory cyto-
kine response compared to mice infected with 
B. cereus alone. TNF-α levels increased slightly, 
although the difference was not significant. 
However, mice infected with SIC carvacrol-
treated B. cereus had significantly higher de- 
tectable IL-6 levels in the spleen than those of 
all other treatment groups. In fact, the SIC car-
vacrol-treated mice were not significantly differ-
ent than the mice injected intraperitoneally 
with B. cereus in terms of IL-6 production; the 
latter of which served as a positive control for 
this cytokine ELISA. This observation indicates 
B. cereus escaped the confines of the eye and 
progressed systemically. Histological analysis 
confirmed that B. cereus stressed with the SIC 
of carvacrol resulted in more tissue damage to 
the eye than untreated B. cereus. However, 
mice infected with B. cereus and the SIC of 
carvacrol did not exhibit significantly more eye 
damage than mice treated with the SIC of car-
vacrol alone, suggesting that carvacrol alone 
was a modest irritant. However, mice treated 
with carvacrol alone did not display any exter-
nal signs of irritation during the 14 d immune 
challenge nor did this group display any detect-
able cytokines from ELISA. 
The increased levels of pro-inflammatory cyto-
kines and anti-B. cereus IgG levels show that 
the SIC of carvacrol did increase the virulence 
of B. cereus during endophthalmitis, consistent 
with our C. elegans data, and the in vitro ex- 
periments. However, another possibility in the 
mouse model is that carvacrol elicited damage 
to the blood-retinal barrier and allowed B. cere-
us to escape the eye more readily, rather than 
the escape being only mediated by bacterial 
products. The third and most likely possibility, 
all factors considered, is that the effects seen 
here are a combination of increased bacterial 
virulence from sublethal stress, and carvacrol 
effects on retinal tissue. 
Rose Bengal was chosen for this experiment 
because it is commonly used to stain ocular tis-
sue damage specifically, especially in the form 
of eye drops in vivo [29]. Prior to this experi-
ment, it was not known how Rose Bengal would 
stain specific intraocular structures. Thus, over-
all damage to the eye was analyzed instead of 
specific region comparison. Images were nor-
malized to the eyes treated with saline, to ma- 
intain consistency with the treatments used to 
obtain ELISA results. 
It is important to understand the response of 
B. cereus to the SIC of carvacrol in the ocular 
environment because carvacrol may be a po- 
tential alternative treatment for endophthalmi-
tis caused by B. cereus, due to its antimicrobial 
and anti-inflammatory qualities [30]. However, 
practitioners should be clear on the benefits 
and the consequences of using carvacrol as a 
possible treatment option. Although the mini-
mum inhibitory concentration (MIC) would be 
the dose administered to patients, it is possible 
that carvacrol could have trouble penetrating 
the vitreous of the eye when given in the form 
of eye drops. It is therefore possible that pa- 
tients treated with the MIC of carvacrol could 
actually be receiving lower levels intraocularly. 
For this reason, it is important to understand 
the effects of sublethal levels of carvacrol on 
the eye. This study, in combination with previ-
ous research done in this laboratory, has sh- 
own that the SIC of carvacrol may increase the 
virulence of B. cereus. Therefore, it is possible 
that patients receiving the SIC of carvacrol 
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could have a more virulent B. cereus eye infec-
tion, resulting in more eye tissue damage than 
the bacteria would have caused by itself.
In order to answer some of the questions gen-
erated from this study, we propose the use of 
retinal pigment epithelial (RPE) cells in vitro to 
assess damage done to retinal cells by the SIC 
of carvacrol alone. RPE cells make up the outer 
layer of the blood-retinal barrier. We will also 
quantify tight junction protein expression in 
RPE cells infected with B. cereus grown in the 
SIC of carvacrol compared to cells infected wi- 
th the bacteria alone. These studies will deter-
mine if the SIC of carvacrol causes damage by 
testing for cytotoxicity to RPE cells or disruption 
of tight junctions within the blood-retinal barri-
er. After assessing the effects of subinhibitory 
carvacrol concentrations on RPE cells in vitro, 
another in vivo mouse model experiment may 
be performed to determine if B. cereus stressed 
with the SIC of carvacrol causes the bacteria to 
increase its toxin production within the eye. 
This study would answer the question of wheth-
er or not B. cereus actively produces toxins in 
the ocular environment, and if so, at what ti- 
me-point is toxin production at its highest. It is 
important to provide answers to these ques-
tions, because gaining a better understanding 
the way B. cereus behaves in the ocular envi-
ronment could affect endophthalmitis treat-
ment regimes. 
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